The highest dose of the investigational drug iberdomide showed a reduction of lupus symptoms by the end of a 24-week, Phase 2 study. OMRF physician-scientist Joan Merrill, M.D., was the lead author of the paper.
VeloCity staff recently visited with OMRF’s new president Dr. Andrew Weyrich to learn more about him, both professionally and personally, and to hear his thoughts about OMRF and his new role there.
After a two-year break due to the pandemic, the Chamber will resume its annual DC Fly-in this year on April 27-28, to provide Chamber members with an opportunity to interact one-on-one with members of Oklahoma’s congressional delegation and defense leaders.
Publisher Bisnow Media recently profiled Oklahoma City among those cities where "innovation and expertise exist" in ways that set up the local life sciences industry for future growth.
Officially launched by nonprofit Progress OKC with the Oklahoma City Economic Development Trust, Inasmuch Foundation and the Chamber serving as initial investors, Kiva Oklahoma City provides small businesses with micro-loans ranging from just $1 all the way up to $15,000.
After a successful first cohort of startups, gBETA Oklahoma City, developed by nationally ranked startup accelerator gener8tor and supported by the Chamber, the Inasmuch Foundation and other community partners, is now accepting applications for the second cohort.
“Support for entrepreneurship is a key component of Forward OKC VI and likewise is imperative to OKC’s continued economic success,” said Jeff Seymour, Chamber executive vice president of economic development.
Andrew S. Weyrich, Ph.D., Monday joined the Oklahoma Medical Research Foundation as its president.
